Milestones

1. A Critical Evaluation of ARMA in Gastroesophageal Reflux Disease, Contributing to the Optimization of Evidence-Based Treatment Strategies. Rodríguez de Santiago E, Teruel Sánchez-Vegazo C, Albéniz E, Estremera Arévalo F, Arrubla Gamboa A, Castel I, Arribas Anta J, Marín-Gabriel JC, Díez Redondo P, Núñez Rodríguez H, Herreros De Tejada A, El Hajra Martínez I, Riu Pons F, Naves JE, Uchima H, Marín I, Duque Alcorta JM, Pérez Corte D, De María Pallarés P, Pérez Enciso I, García Suarez C, Lorenzo Zúñiga V, Nogales Ó, Muriel A, Albillos A; ECA-ARMA authors of the Mucosal Resection and Third-Space Endoscopy SEED Working Group. Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease. Endoscopy. 2026. doi: 10.1055/a-2780-0706. PMID: 41475422.
2. Development of strategies for the early identification of portopulmonary hypertension in patients with cirrhosis, with potential implications for prognosis and clinical decision-making. Téllez L, Donate J, Guerrero A, Agulleiro Beraza I, San Martín D, Alvarado E, Echevarría V, Puente Á, Zamora J, Prado SD, Tenes A, Balagué G, Vidal B, Geli C, Rodríguez-Gandía MÁ, Baiges A, Brujats A, López-Herrera Rodríguez D, Fernández-Gordón Sánchez S, Fortea JI, del Cerro M Jesús, Villanueva C, García-Pagán JC, Giráldez Á, Albillos A. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort. J Hepatol. 2026;84(2):284-292. doi: 10.1016/j.jhep.2025.09.011 PMID: 41076090.
3. Characterization of a new hemodynamic phenotype in patients with Fontan circulation, providing insights into its pathophysiology and clinical follow-up. Téllez L, Toledano M, Álvarez M, Garrido-Lestache E, Garrido E, Guerrero A, Donate J, Canova L, Torres M, Perna C, Del Cerro MJ, Albillos A. Distinctive hemodynamic phenotype in patients with Fontan-type circulation and distal esophageal varices. Hepatology. 2026;83(5):1192-1203. doi: 10.1097/HEP.0000000000001472. PMID: 40694806.
4. Leadership of the Spanish Consensus Guidelines on the Diagnosis and Treatment of Portal Hypertension, consolidating the group's leadership in the development of national clinical reference documents. Albillos A, Bañares R, Hernández-Gea V; on behalf of the Spanish Consensus Group on Portal Hypertension. Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd). Gastroenterol Hepatol. 2025;48(1):502208. doi: 10.1016/j.gastrohep.2024.502208. PMID: 39756832.
5. Optimizing the collection of pancreatic cancer samples for genetic studies using EUS-FNA, promoting personalized medicine. Ligato I, García García de Paredes A, López Duran S, Gonzalez Garcia I, Benito Berlinches A, Romio de Las Heras E, Caminoa Lizarralde A, Santón Roldán A, Rodríguez Garrote M, Ponce CG, Defarges V, Foruny Olcina JR, Albillos A, Vázquez Sequeiros E. Utility of endoscopic ultrasound-guided fine needle aspiration for genetic analysis in pancreatic ductal adenocarcinoma. HPB (Oxford). 2025;27(3):414-416. doi: 10.1016/j.hpb.2024.11.009. PMID: 39674743.